Genetic risk of acute pulmonary infections and sepsis

References

• Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med.318(12), 727–732 (1988).
   PubMed Web of Science ®Google Scholar
• Burgner D, Jamieson SE, Blackwell JM. Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? Lancet Infect. Dis.6(10), 653–663 (2006).
   PubMed Web of Science ®Google Scholar
• Murphy PM. Molecular mimicry and the generation of host defense protein diversity. Cell72(6), 823–826 (1993).
   PubMedGoogle Scholar
• Waterer GW. Polymorphism studies in critical illness – we have to raise the bar. Crit. Care Med.35(5), 1424–1425 (2007).
   PubMedGoogle Scholar
• Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun.7(2), 85–94 (2006).
   PubMed Web of Science ®Google Scholar
• Gordon A, Waheed U, Hansen T et al. Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome. Shock25(1), 88–93 (2006).
   PubMed Web of Science ®Google Scholar
• Garred P, Strøm J, Quist L, Taaning E, Madsen H. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J. Infect. Dis.188(9), 1394–1403 (2003).
   PubMed Web of Science ®Google Scholar
• Kronborg G, Weis N, Madsen H et al. Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients. J. Infect. Dis.185(10), 1517–1520 (2002).
   PubMed Web of Science ®Google Scholar
• Henckaerts L, Nielsen KR, Steffensen R et al. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit. Care Med.37(1), 192–201, e1–e3 (2009).
   PubMed Web of Science ®Google Scholar
• Endeman H, Herpers BL, de Jong BA et al. Mannose-binding lectin genotypes in susceptibility to community-acquired pneumonia. Chest134(6), 1135–1140 (2008).
   PubMedGoogle Scholar
• Herpers BL, Yzerman EP, de Jong BA et al. Deficient mannose-binding lectin-mediated complement activation despite mannose-binding lectin-sufficient genotypes in an outbreak of Legionella pneumophila pneumonia. Hum. Immunol.70(2), 125–129 (2009).
   PubMedGoogle Scholar
• Roy S, Knox K, Segal S et al. MBL genotype and risk of invasive pneumococcal disease: a case–control study. Lancet359(9317), 1569–1573 (2002).
   PubMed Web of Science ®Google Scholar
• Moens L, Van Hoeyveld E, Peetermans WE, De Boeck C, Verhaegen J, Bossuyt X. Mannose-binding lectin genotype and invasive pneumococcal infection. Hum. Immunol.67(8), 605–611 (2006).
   PubMedGoogle Scholar
• Brouwer MC, de Gans J, Heckenberg SG, Zwinderman AH, van der Poll T, van de Beek D. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect. Dis.9(1), 31–44 (2009).
   PubMed Web of Science ®Google Scholar
• Yuan FF, Marks K, Wong M et al. Clinical relevance of TLR2, TLR4, CD14 and FcγRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol. Cell Biol.86(3), 268–270 (2008).
   PubMed Web of Science ®Google Scholar
• Yee AM, Ng SC, Sobel RE, Salmon JE. FcγRIIA polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus. Arthritis Rheum.40(6), 1180–1182 (1997).
   PubMed Web of Science ®Google Scholar
• Yuan FF, Wong M, Pererva Net al.FcγRIIA polymorphisms in Streptococcus pneumoniae infection. Immunol. Cell Biol.81(3), 192–195 (2003).
   PubMed Web of Science ®Google Scholar
• Moens L, Van Hoeyveld E, Verhaegen J, De Boeck K, Peetermans WE, Bossuyt X. Fcγ-receptor IIA genotype and invasive pneumococcal infection. Clin. Immunol.118(1), 20–23 (2006).
   PubMed Web of Science ®Google Scholar
• van der Pol WL, Huizinga TW, Vidarsson G et al. Relevance of Fcγ receptor and interleukin-10 polymorphisms for meningococcal disease. J. Infect. Dis.184(12), 1548–1555 (2001).
   PubMed Web of Science ®Google Scholar
• D’Avila LC, Albarus MH, Franco CR et al. Effect of CD14 -260C>T polymorphism on the mortality of critically ill patients. Immunol. Cell Biol.84(4), 342–348 (2006).
   PubMedGoogle Scholar
• Barber R, Chang L, Arnoldo BD et al. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin. Med. Res.4(4), 250–255 (2006).
   PubMedGoogle Scholar
• Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit. Care Med.30(5), 969–973 (2002).
   PubMed Web of Science ®Google Scholar
• Lin J, Yao YM, Huang ZH, Hou XX, Zhu JM, Chai JK. [Association between a genomic polymorphism within the CD14 locus and severe sepsis susceptibility as well as prognosis in patients after extensive burns]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue16(5), 271–273 (2004).
   PubMedGoogle Scholar
• Sutherland AM, Walley KR, Russell JA. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit. Care Med.33(3), 638–644 (2005).
   PubMed Web of Science ®Google Scholar
• Heesen M, Bloemeke B, Schade U, Obertacke U, Majetschak M. The -260 C→T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients. Intensive Care Med.28(8), 1161–1163 (2002).
   PubMed Web of Science ®Google Scholar
• Hubacek JA, Stuber F, Frohlich D et al. The common functional C(-159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality. Genes Immun.1(6), 405–407 (2000).
   PubMed Web of Science ®Google Scholar
• Nakada TA, Hirasawa H, Oda S et al. Influence of Toll-like receptor 4, CD14, tumor necrosis factor, and interleukin-10 gene polymorphisms on clinical outcome in japanese critically ill patients. J. Surg. Res. (2005).
   PubMedGoogle Scholar
• Lin J, Yao YM, Huang ZH et al. [The influence of CD14 genomic polymorphism on CD14 gene expression as well as protein release and its clinical significance in patients with extensive burns]. Zhonghua Wai Ke Za Zhi44(13), 907–910 (2006).
   PubMedGoogle Scholar
• de Aguiar BB, Girardi I, Paskulin DD et al. CD14 expression in the first 24h of sepsis: effect of -260C>T CD14 SNP. Immunol. Invest.37(8), 752–769 (2008).
   PubMedGoogle Scholar
• Temple SE, Cheong KY, Almeida CM, Price P, Waterer GW. Polymorphisms in lymphotoxin α and CD14 genes influence TNFα production induced by Gram-positive and Gram-negative bacteria. Genes Immun.4(4), 283–288 (2003).
   PubMedGoogle Scholar
• Weiss J. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria. Biochem. Soc. Trans.31(Pt 4), 785–790 (2003).
   PubMed Web of Science ®Google Scholar
• Michalek J, Svetlikova P, Fedora M et al. Bactericidal permeability increasing protein gene variants in children with sepsis. Intensive Care Med.33(12), 2158–2164 (2007).
   PubMed Web of Science ®Google Scholar
• Hubacek JA, Stuber F, Frohlich D et al. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit. Care Med.29(3), 557–561 (2001).
   PubMed Web of Science ®Google Scholar
• Beutler B. Toll-like receptors: how they work and what they do. Curr. Opin. Hematol.9(1), 2–10 (2002).
   PubMedGoogle Scholar
• Barber RC, Chang LY, Arnoldo BD et al. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin. Med. Res.4(4), 250–255 (2006).
   PubMedGoogle Scholar
• Lorenz E, Mira J, Frees K, Schwartz D. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch. Intern. Med.162(9), 1028–1032 (2002).
   PubMed Web of Science ®Google Scholar
• Jessen KM, Lindboe SB, Petersen AL, Eugen-Olsen J, Benfield T. Common TNF-α, IL-1 β, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis. BMC Infect. Dis.7, 108 (2007).
   PubMedGoogle Scholar
• Moens L, Verhaegen J, Pierik M et al. Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease. Microbes Infect.9(1), 15–20 (2007).
   PubMed Web of Science ®Google Scholar
• Yoon HJ, Choi JY, Kim CO et al. Lack of Toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia. J. Korean Med. Sci.21(6), 979–982 (2006).
   PubMedGoogle Scholar
• Brenmoehl J, Herfarth H, Gluck T et al. Genetic variants in the NOD2/CARD15 gene are associated with early mortality in sepsis patients. Intensive Care Med.33(9), 1541–1548 (2007).
   PubMedGoogle Scholar
• Everett B, Cameron B, Li H et al. Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever. Genes Immun.8(8), 699–702 (2007).
   PubMed Web of Science ®Google Scholar
• Hawn TR, Verbon A, Lettinga KD et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires’ disease. J. Exp. Med.198(10), 1563–1572 (2003).
   PubMed Web of Science ®Google Scholar
• Wurfel MM, Gordon AC, Holden TD et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am. J. Respir. Crit. Care Med.178(7), 710–720 (2008).
   PubMed Web of Science ®Google Scholar
• Khor CC, Chapman SJ, Vannberg FO et al. A MAL functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat. Genet.39(4), 523–528 (2007).
   PubMed Web of Science ®Google Scholar
• Gu W, Shan Y, Zhou J et al. Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2. Ann. Surg.246(1), 151–158 (2007).
   PubMed Web of Science ®Google Scholar
• Arcaroli J, Silva E, Maloney J et al. Variant IRAK-1 haplotype is associated with increased nuclear factor-κB activation and worse outcomes in sepsis. Am. J. Respir. Crit. Care Med.173(12), 1335–1341 (2006).
   PubMedGoogle Scholar
• Chapman SJ, Khor CC, Vannberg FOet al.IκB genetic polymorphisms and invasive pneumococcal disease. Am. J. Respir. Crit. Care Med.176(2), 181–187 (2007).
   PubMed Web of Science ®Google Scholar
• Chapman SJ, Khor CC, Vannberg FOet al.NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations. Genes Immun. DOI:10.1038/gene.2009.76 (2009 ) (Epub ahead of print).
   PubMedGoogle Scholar
• Ku CL, Picard C, Erdos Met al.IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease. J. Med. Genet.44(1), 16–23 (2007).
   PubMed Web of Science ®Google Scholar
• Menges T, Konig IR, Hossain H et al. Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factor. Crit. Care Med.36(5), 1456–1462, e1–e6 (2008).
   PubMedGoogle Scholar
• Schueller AC, Heep A, Kattner E et al. Prevalence of two tumor necrosis factor gene polymorphisms in premature infants with early onset sepsis. Biol. Neonate90(4), 229–232 (2006).
   PubMedGoogle Scholar
• Azim K, McManus R, Brophy K, Ryan A, Kelleher D, Reynolds JV. Genetic polymorphisms and the risk of infection following esophagectomy positive association with TNF-α gene -308 genotype. Ann. Surg.246(1), 122–128 (2007).
   PubMedGoogle Scholar
• O’Keefe GE, Hybki DL, Munford RS. The G→A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-α promoter increases the risk for severe sepsis after trauma. J. Trauma52(5), 817–825; discussion 825–816 (2002).
   PubMed Web of Science ®Google Scholar
• Mira JP, Cariou A, Grall F et al. Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA282(6), 561–568 (1999).
   PubMed Web of Science ®Google Scholar
• Cipriano C, Caruso C, Lio D et al. The -308G/A polymorphism of TNF-α influences immunological parameters in old subjects affected by infectious diseases. Int. J. Immunogenet.32(1), 13–18 (2005).
   PubMedGoogle Scholar
• Hedberg CL, Adcock K, Martin J, Loggins J, Kruger TE, Baier RJ. Tumor necrosis factor α – 308 polymorphism associated with increased sepsis mortality in ventilated very low birth weight infants. Pediatr. Infect. Dis. J.23(5), 424–428 (2004).
   PubMedGoogle Scholar
• Nuntayanuwat S, Dharakul T, Chaowagul W, Songsivilai S. Polymorphism in the promoter region of tumor necrosis factor-α gene is associated with severe meliodosis. Hum. Immunol.60(10), 979–983 (1999).
   PubMedGoogle Scholar
• Stuber F, Udalova IA, Book M et al. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J. Inflamm.46(1), 42–50 (1995).
   PubMedGoogle Scholar
• Calvano JE, Um JY, Agnese DM et al. Influence of the TNF-α and TNF-β polymorphisms upon infectious risk and outcome in surgical intensive care patients. Surg. Infect. (Larchmt)4(2), 163–169 (2003).
   PubMedGoogle Scholar
• Westendorp RG, Langermans JA, Huizinga TW et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet349(9046), 170–173 (1997).
   PubMed Web of Science ®Google Scholar
• Waterer GW, Quasney MW, Cantor RM, Wunderink RG. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am. J. Respir. Crit. Care Med.163(7), 1599–1604 (2001).
   PubMed Web of Science ®Google Scholar
• Pappachan JV, Coulson TG, Child NJ et al. Mortality in adult intensive care patients with severe systemic inflammatory response syndromes is strongly associated with the hypo-immune TNF-238A polymorphism. Immunogenetics61(10), 657–662 (2009).
   PubMedGoogle Scholar
• Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun.5(5), 315–329 (2004).
   PubMed Web of Science ®Google Scholar
• Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit. Care Med.24(3), 381–384 (1996).
   PubMed Web of Science ®Google Scholar
• Majetschak M, Flohe S, Obertacke U et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann. Surg.230(2), 207–214 (1999).
   PubMedGoogle Scholar
• Temple SE, Cheong KY, Ardlie KG, Sayer D, Waterer GW. The septic shock associated HSPA1B1267 polymorphism influences production of HSPA1A and HSPA1B. Intensive Care Med.30(9), 1761–1767 (2004).
   PubMed Web of Science ®Google Scholar
• Waterer GW, ElBahlawan L, Quasney MW, Zhang Q, Kessler LA, Wunderink RG. Heat shock protein 70–72+1267 AA homozygotes have an increased risk of septic shock in adults with community-acquired pneumonia. Crit. Care Med.31(5), 1367–1372 (2003).
   PubMed Web of Science ®Google Scholar
• Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 β (IL-1 β) gene correlates with IL-1 β secretion in vitro. Eur. J. Clin. Invest.22(6), 396–402 (1992).
   PubMed Web of Science ®Google Scholar
• Read RC, Camp NJ, diGiovine FS et al. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J. Infect. Dis.182(5), 1557–1560 (2000).
   PubMedGoogle Scholar
• Fang XM, Schroder S, Hoeft A, Stuber F. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit. Care Med.27(7), 1330–1334 (1999).
   PubMed Web of Science ®Google Scholar
• Arnalich F, Lopez-Maderuelo D, Codoceo R et al. Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin. Exp. Immunol.127(2), 331–336 (2002).
   PubMedGoogle Scholar
• Ma P, Chen D, Pan J, Du B. Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients. Crit. Care Med.30(5), 1046–1050 (2002).
   PubMedGoogle Scholar
• Schluter B, Raufhake C, Erren M et al. Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit. Care Med.30(1), 32–37 (2002).
   PubMed Web of Science ®Google Scholar
• Sutherland AM, Walley KR, Manocha S, Russell JA. The association of interleukin 6 haplotypeclades with mortality in critically ill adults. Arch. Intern. Med.165(1), 75–82 (2005).
   PubMed Web of Science ®Google Scholar
• Baier R, Loggins J, Yanamandra K. IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Med.12(4), 10–12 (2006).
   Google Scholar
• Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol.3(10), 791–800 (2003).
   PubMed Web of Science ®Google Scholar
• Gao L, Flores C, Fan-Ma S et al. Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations. Trans. Res.150(1), 18–29 (2007).
   Google Scholar
• Yende S, Angus DC, Kong Let al.The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia. FASEB J.23(8), 2403–2411 (2009).
   PubMed Web of Science ®Google Scholar
• Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet.24(1), 1–8 (1997).
   PubMedGoogle Scholar
• Temple SE, Lim E, Cheong KY et al. Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics55(9), 629–632 (2003).
   PubMed Web of Science ®Google Scholar
• Schaaf BM, Boehmke F, Esnaashari H et al. Pneumococcal septic shock is associated with the interleukin-10–1082 gene promoter polymorphism. Am. J. Respir. Crit. Care Med.168(4), 476–480 (2003).
   PubMed Web of Science ®Google Scholar
• Gallagher PM, Lowe G, Fitzgerald T et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax58(2), 154–156 (2003).
   PubMed Web of Science ®Google Scholar
• Stanilova SA, Miteva LD, Karakolev ZT, Stefanov CS. Interleukin-10–1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med.32(2), 260–266 (2006).
   PubMed Web of Science ®Google Scholar
• Gong MN, Thompson BT, Williams PL et al. Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome. Eur. Respir. J.27(4), 674–681 (2006).
   PubMedGoogle Scholar
• Shu Q, Fang X, Chen Q, Stuber F. IL-10 polymorphism is associated with increased incidence of severe sepsis. Chin. Med. J. (Engl.)116(11), 1756–1759 (2003).
   PubMedGoogle Scholar
• Wattanathum A, Manocha S, Groshaus H, Russell JA, Walley KR. Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest128(3), 1690–1698 (2005).
   PubMedGoogle Scholar
• Bastarache JA, Ware LB, Bernard GR. The role of the coagulation cascade in the continuum of sepsis and acute lung injury and acute respiratory distress syndrome. Semin. Respir. Crit. Care Med.27(4), 365–376 (2006).
   PubMed Web of Science ®Google Scholar
• Weiler H, Kerlin B, Lytle MC. Factor V Leiden polymorphism modifies sepsis outcome: evidence from animal studies. Crit. Care Med.32(5 Suppl.), S233–S238 (2004).
   Google Scholar
• Yan SB, Nelson DR. Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C. Crit. Care Med.32(5 Suppl.), S239–S246 (2004).
   PubMed Web of Science ®Google Scholar
• Chen QX, Wu SJ, Wang HH et al. Protein C -1641A/-1654C haplotype is associated with organ dysfunction and the fatal outcome of severe sepsis in Chinese Han population. Hum. Genet.123(3), 281–287 (2008).
   PubMedGoogle Scholar
• Walley K, Russell J. Protein C-1641 AA is associated with decreased survival and more organ dysfunction in severe sepsis. Crit. Care Med.35(1), 12–17 (2007).
   PubMedGoogle Scholar
• Russell JA. Genetics of coagulation factors in acute lung injury. Crit. Care Med.31(4 Suppl.), S243–S247 (2003).
   Google Scholar
• Geishofer G, Binder A, Muller M et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Eur. J. Pediatr.164(8), 486–490 (2005).
   PubMed Web of Science ®Google Scholar
• Haralambous E, Hibberd ML, Hermans PW, Ninis N, Nadel S, Levin M. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit. Care Med.31(12), 2788–2793 (2003).
   PubMed Web of Science ®Google Scholar
• Hermans PW, Hibberd ML, Booy R et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet354(9178), 556–560 (1999).
   PubMed Web of Science ®Google Scholar
• Westendorp RG, Hottenga JJ, Slagboom PE. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet354(9178), 561–563 (1999).
   PubMed Web of Science ®Google Scholar
• Binder A, Endler G, Muller M, Mannhalter C, Zenz W. 4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia. J. Thromb. Haemost.5(10), 2049–2054 (2007).
   PubMed Web of Science ®Google Scholar
• Domingo P, Muniz-Diaz E, Baraldes MA et al. Relevance of genetically determined host factors to the prognosis of meningococcal disease. Eur. J. Clin. Microbiol. Infect. Dis.23(8), 634–637 (2004).
   PubMedGoogle Scholar
• Yende S, Angus DC, Ding J et al. 4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia. Am. J. Respir. Crit. Care Med.176(11), 1129–1137 (2007).
   PubMedGoogle Scholar
• Sapru A, Hansen H, Ajayi T et al. 4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumonia. Anesthesiology110(5), 1086–1091 (2009).
   PubMedGoogle Scholar
• Chen QX, Lv C, Huang LX et al. Genomic variations within DEFB1 are associated with the susceptibility to and the fatal outcome of severe sepsis in Chinese Han population. Genes Immun.8(5), 439–443 (2007).
   PubMedGoogle Scholar
• Stassen NA, Breit CM, Norfleet LA, Polk HC Jr. IL-18 promoter polymorphisms correlate with the development of post-injury sepsis. Surgery134(2), 351–356 (2003).
   PubMedGoogle Scholar
• Stassen NA, Leslie-Norfleet LA, Robertson AM, Eichenberger MR, Polk HC Jr. Interferon-γ gene polymorphisms and the development of sepsis in patients with trauma. Surgery132(2), 289–292 (2002).
   PubMedGoogle Scholar
• Flores C, Maca-Meyer N, Perez-Mendez L et al. A CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish population. Genes Immun.7(2), 141–149 (2006).
   PubMedGoogle Scholar
• Chen Q, Zhou H, Wu S et al. Lack of association between TREM-1 gene polymorphisms and severe sepsis in a Chinese Han population. Hum. Immunol.69(3), 220–226 (2008).
   PubMed Web of Science ®Google Scholar
• Payton A, Payne D, Mankhambo LA et al. Nitric oxide synthase 2A (NOS2A) polymorphisms are not associated with invasive pneumococcal disease. BMC Med. Genet.10, 28 (2009).
   PubMedGoogle Scholar
• Moretti EW, Morris RW, Podgoreanu M et al. APOE polymorphism is associated with risk of severe sepsis in surgical patients. Crit. Care Med.33(11), 2521–2526 (2005).
   PubMed Web of Science ®Google Scholar
• Bunker-Wiersma HE, Koopmans RP, Kuipers TW, Knoester H, Bos AP. Single nucleotide polymorphisms in genes of circulatory homeostasis in surviving pediatric intensive care patients with meningococcal infection. Pediatr. Crit. Care Med.9(5), 517–523 (2008).
   PubMedGoogle Scholar
• Kleiman DA, Calvano JE, Coyle SM, Macor MA, Calvano SE, Lowry SF. A single nucleotide polymorphism in the Mdm2 promoter and risk of sepsis. Am. J. Surg.197(1), 43–48 (2009).
   PubMedGoogle Scholar